Humana (NYSE:HUM) updated its FY 2019
After-Hours earnings guidance on Monday. The company provided EPS guidance of 17.75-17.75 for the period, compared to the Thomson Reuters consensus EPS estimate of $17.77.
Several analysts have issued reports on the stock. SunTrust Banks upped their price target on shares of Humana to $350.00 and gave the company a hold rating in a report on Friday, November 15th. They noted that the move was a valuation call. Mizuho assumed coverage on shares of Humana in a report on Thursday, October 17th. They issued a buy rating and a $316.00 price target on the stock. BMO Capital Markets downgraded shares of Humana from an outperform rating to a market perform rating and reduced their price target for the company from $345.00 to $290.00 in a report on Monday, September 30th. Deutsche Bank assumed coverage on shares of Humana in a report on Thursday, September 12th. They issued a hold rating and a $300.00 price target on the stock. Finally, Morgan Stanley reaffirmed a buy rating and issued a $360.00 price target (up previously from $337.00) on shares of Humana in a report on Monday, November 18th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and thirteen have assigned a buy rating to the stock. The company presently has an average rating of Buy and an average target price of $324.82.
Shares of HUM traded down $2.98 on Monday, hitting $338.25. 813,702 shares of the stock traded hands, compared to its average volume of 1,208,841. The company has a quick ratio of 1.83, a current ratio of 1.83 and a debt-to-equity ratio of 0.46. The firm has a market capitalization of $45.19 billion, a P/E ratio of 23.25, a P/E/G ratio of 1.46 and a beta of 0.90. The stock’s 50 day moving average is $306.03 and its two-hundred day moving average is $279.33. Humana has a 1 year low of $225.65 and a 1 year high of $345.71.
Humana (NYSE:HUM) last announced its quarterly earnings data on Wednesday, November 6th. The insurance provider reported $5.03 earnings per share (EPS) for the quarter, beating the consensus estimate of $4.58 by $0.45. The business had revenue of $16.24 billion for the quarter, compared to the consensus estimate of $16.15 billion. Humana had a net margin of 4.06% and a return on equity of 22.32%. The company’s quarterly revenue was up 14.3% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $4.58 earnings per share. Research analysts forecast that Humana will post 17.77 EPS for the current year.
The business also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Tuesday, December 31st will be paid a dividend of $0.55 per share. This represents a $2.20 dividend on an annualized basis and a yield of 0.65%. The ex-dividend date is Monday, December 30th. Humana’s dividend payout ratio is currently 15.12%.
Humana Inc, together with its subsidiaries, operates as a health and well-being company in the United States. The company offers medical and supplemental benefit plans to individuals. It also has contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.
Recommended Story: Why Invest in High-Yield Dividend Stocks?
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.